Post-marketing Clinical Study of Rebamipide in Patients With Gastric Ulcer
Status:
Completed
Trial end date:
2005-09-09
Target enrollment:
Participant gender:
Summary
To examine the efficacy of continued administration of rebamipide following bacteria
eradication therapy in patients with H. pylori-positive active gastric ulcer in a
placebo-controlled, double-blind study